Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume 22, Issue 9, Pages 1743-1752Publisher
AMER SOC CLINICAL ONCOLOGY
DOI: 10.1200/JCO.2004.06.147
Keywords
-
Categories
Ask authors/readers for more resources
Treatment of squamous cell carcinoma of the head and neck (SCCHN) has evolved greatly in the last two decades, owing to the integration of chemotherapy, advances in radiotherapeutic techniques, and organ-preserving surgery. Several randomized trials have established new standards of care that should be adopted. Current efforts are building on these earlier trials in order to improve survival and quality of life. Coincident with this, investigators are developing molecularly targeted approaches that hold promise for the future. This review will focus on current therapy for locally advanced, recurrent, and metastatic SCCHN and discuss controversies and directions for future research.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available